Managed care
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $11.55M by Medicaid between Jan 2018 and Dec 2024, across 417 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
WOODLAND HILLS, CA 91367
WOODLAND HILLS, CA 91367
33aNPI1952333478assigned 07/07/2006
33bProvider typeHealth Maintenance Organization
28Total paid$11.55M
24GClaims497,197
24DCodes billed417
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#19 of 151
Median peer was paid$59K
This provider vs. median195×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 163,420 | $53K | |
| 2019 | 45,057 | $157K | |
| 2020 | 31,225 | $656K | |
| 2021 | 48,363 | $1.63M | |
| 2022 | 53,004 | $1.72M | |
| 2023 | 66,807 | $2.85M | |
| 2024incomplete | 89,321 | $4.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 34,676 | 33,331 | $2.26M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 24,722 | 24,398 | $2.24M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5.9% | 16,292 | 11,964 | $686K |
| 91320 | 5.9% | 4,398 | 4,395 | $677K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 46,244 | 43,985 | $593K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 4.2% | 3,507 | 2,662 | $485K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 3.4% | 7,231 | 7,069 | $389K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.5% | 13,827 | 8,896 | $288K |
| 90662 | 2.4% | 2,501 | 2,494 | $274K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.3% | 49,363 | 48,828 | $265K |
| 90480 | 2.3% | 5,407 | 5,395 | $264K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 3,545 | 3,297 | $231K |
405 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 13,161 | $167K |
| 92015 | Determination of refractive state | 1.4% | 18,158 | $159K |
| 99283 | Emergency room visit (moderate) | 1.1% | 4,267 | $132K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 1,445 | $122K |
| 0001A | <1% | 2,780 | $107K | |
| 0002A | <1% | 2,709 | $106K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 534 | $101K |
| 99285 | Emergency room visit (most serious) | <1% | 944 | $97K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,031 | $91K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,456 | $78K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,535 | $78K |
| 0012A | <1% | 1,968 | $77K | |
| 0064A | <1% | 1,765 | $72K | |
| 90686 | <1% | 22,605 | $71K | |
| 76641 | <1% | 2,456 | $71K | |
| 99223 | Prolong inpt eval add15 m | <1% | 577 | $71K |
| 0011A | <1% | 1,938 | $70K | |
| 71045 | Radiologic examination, chest; single view | <1% | 11,813 | $66K |
| 93970 | <1% | 230 | $53K | |
| 0124A | <1% | 1,642 | $52K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 408 | $42K |
| 0134A | <1% | 1,098 | $39K | |
| 62322 | <1% | 158 | $39K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 149 | $38K |
| 99442 | <1% | 613 | $37K | |
| 77080 | <1% | 2,558 | $36K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,559 | $36K |
| 0004A | <1% | 783 | $31K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,256 | $31K |
| 0054A | <1% | 711 | $30K | |
| 92002 | <1% | 1,292 | $29K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 723 | $26K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,121 | $25K |
| 90750 | <1% | 336 | $24K | |
| 93880 | <1% | 54 | $19K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,841 | $18K |
| 0071A | <1% | 450 | $18K | |
| 93296 | <1% | 251 | $17K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 924 | $16K |
| 93294 | <1% | 188 | $16K | |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | <1% | 422 | $16K |
| 99443 | <1% | 179 | $16K | |
| 77066 | Tomosynthesis, mammo | <1% | 191 | $16K |
| 20610 | <1% | 243 | $16K | |
| 0072A | <1% | 363 | $14K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,004 | $13K |
| 99441 | <1% | 1,587 | $13K | |
| 11055 | <1% | 116 | $13K | |
| 77065 | Tomosynthesis, mammo | <1% | 148 | $13K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 140 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 206 | $12K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,029 | $12K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,602 | $12K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 6,599 | $11K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,389 | $10K |
| 92551 | <1% | 6,624 | $10K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 752 | $10K |
| 97161 | <1% | 517 | $10K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,336 | $9K |
| 92567 | <1% | 703 | $9K | |
| 83921 | <1% | 321 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,630 | $8K |
| 90656 | <1% | 1,798 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 275 | $8K |
| 92557 | <1% | 303 | $8K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,218 | $8K |
| 11721 | <1% | 141 | $8K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,151 | $8K |
| 90677 | <1% | 167 | $8K | |
| 90674 | <1% | 596 | $8K | |
| 92523 | <1% | 158 | $7K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 719 | $7K |
| 90694 | <1% | 63 | $6K | |
| 0031A | <1% | 147 | $6K | |
| 99220 | <1% | 30 | $6K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 772 | $5K |
| 76813 | <1% | 219 | $5K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 135 | $5K |
| 76830 | Ultrasound, transvaginal | <1% | 660 | $5K |
| 90679 | <1% | 28 | $5K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 231 | $4K |
| 73562 | <1% | 750 | $4K | |
| 90670 | <1% | 1,116 | $4K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 341 | $4K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 448 | $3K |
| 73030 | <1% | 535 | $3K | |
| 73630 | <1% | 809 | $3K | |
| 62323 | <1% | 25 | $3K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 10,803 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 586 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,150 | $3K |
| 97597 | <1% | 29 | $3K | |
| 72100 | <1% | 364 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 390 | $3K |
| 73221 | <1% | 17 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 75 | $2K |
| 90715 | <1% | 600 | $2K | |
| 91319 | <1% | 84 | $2K | |
| 85027 | <1% | 4,529 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 691 | $2K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 97 | $2K |
| 20611 | <1% | 13 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,484 | $2K |
| 0154A | <1% | 47 | $2K | |
| 94729 | <1% | 14 | $2K | |
| 92134 | <1% | 145 | $2K | |
| 94726 | <1% | 14 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 199 | $1K |
| 76536 | <1% | 146 | $1K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 27 | $1K |
| J7999 | Compounded drug, not otherwise classified | <1% | 14 | $1K |
| 90723 | <1% | 675 | $1K | |
| 99173 | <1% | 4,476 | $1K | |
| 95117 | <1% | 192 | $1K | |
| 69210 | <1% | 12 | $1K | |
| 73130 | <1% | 258 | $949.06 | |
| 76770 | <1% | 102 | $867.72 | |
| 94060 | <1% | 26 | $777.00 | |
| 90648 | <1% | 1,179 | $753.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 73 | $751.51 |
| 97162 | <1% | 12 | $716.00 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 161 | $680.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 69 | $566.38 |
| 0013A | <1% | 14 | $564.13 | |
| 0003A | <1% | 13 | $520.00 | |
| 80051 | <1% | 3,291 | $515.25 | |
| 81329 | <1% | 25 | $505.00 | |
| 81003 | <1% | 1,761 | $495.86 | |
| 86360 | <1% | 12 | $460.00 | |
| 97165 | <1% | 108 | $450.00 | |
| 82105 | <1% | 288 | $445.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 62 | $428.70 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 112 | $418.31 |
| 99177 | <1% | 350 | $416.00 | |
| 90651 | <1% | 522 | $407.49 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 471 | $407.32 |
| 86359 | <1% | 12 | $380.00 | |
| 88342 | <1% | 93 | $360.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 336 | $330.71 |
| 90633 | <1% | 509 | $252.00 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 14 | $242.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 511 | $241.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 122 | $227.06 |
| 99385 | <1% | 53 | $225.92 | |
| 82565 | <1% | 3,574 | $178.32 | |
| 12001 | <1% | 17 | $174.78 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 824 | $166.92 |
| 73502 | <1% | 111 | $159.59 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 185 | $148.02 |
| 81002 | <1% | 878 | $142.13 | |
| 99417 | Prolong home eval add 15m | <1% | 15 | $140.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 622 | $128.67 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 27 | $120.38 |
| 91318 | <1% | 24 | $106.00 | |
| 85652 | <1% | 515 | $96.05 | |
| 90655 | <1% | 28 | $84.00 | |
| 84460 | <1% | 2,742 | $75.54 | |
| 82247 | <1% | 1,076 | $75.31 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 61 | $68.00 |
| 99201 | <1% | 414 | $67.95 | |
| 87338 | <1% | 184 | $67.20 | |
| 73610 | <1% | 386 | $66.72 | |
| 10060 | <1% | 13 | $53.52 | |
| 74018 | <1% | 200 | $47.80 | |
| 84075 | <1% | 963 | $37.76 | |
| 84132 | <1% | 406 | $35.00 | |
| 99307 | <1% | 41 | $33.96 | |
| 84295 | <1% | 196 | $30.00 | |
| 90785 | <1% | 13 | $29.58 | |
| 96417 | <1% | 38 | $28.30 | |
| 84450 | <1% | 460 | $22.11 | |
| 82947 | <1% | 1,162 | $20.56 | |
| 93971 | <1% | 48 | $15.44 | |
| 73590 | <1% | 103 | $14.40 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 118 | $14.26 |
| 99051 | <1% | 10,939 | $11.20 | |
| 73110 | <1% | 233 | $8.46 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 198 | $6.72 |
| 87081 | <1% | 828 | $5.68 | |
| 81025 | <1% | 555 | $2.77 | |
| G9920 | Screening performed and negative | <1% | 1,049 | $0.02 |
| 1036F | 0% | 7,489 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 2,233 | $0.00 |
| 90696 | 0% | 112 | $0.00 | |
| 92227 | 0% | 246 | $0.00 | |
| 82677 | 0% | 79 | $0.00 | |
| 72040 | 0% | 83 | $0.00 | |
| 90688 | 0% | 13 | $0.00 | |
| 86762 | 0% | 103 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 1,341 | $0.00 |
| 82040 | 0% | 222 | $0.00 | |
| 86780 | 0% | 691 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 549 | $0.00 |
| 87340 | 0% | 605 | $0.00 | |
| 83001 | 0% | 86 | $0.00 | |
| 90716 | 0% | 246 | $0.00 | |
| 94010 | 0% | 30 | $0.00 | |
| 76801 | 0% | 40 | $0.00 | |
| 99217 | 0% | 53 | $0.00 | |
| 73090 | 0% | 82 | $0.00 | |
| 82607 | 0% | 359 | $0.00 | |
| 73120 | 0% | 22 | $0.00 | |
| 20550 | 0% | 52 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 274 | $0.00 |
| 58100 | 0% | 19 | $0.00 | |
| 83550 | 0% | 475 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 574 | $0.00 |
| 86140 | 0% | 202 | $0.00 | |
| 84484 | 0% | 48 | $0.00 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 18 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 3,521 | $0.00 |
| 87255 | 0% | 48 | $0.00 | |
| 83735 | 0% | 162 | $0.00 | |
| 86580 | 0% | 221 | $0.00 | |
| 82728 | 0% | 475 | $0.00 | |
| 87088 | 0% | 1,633 | $0.00 | |
| 84153 | 0% | 163 | $0.00 | |
| 82670 | 0% | 75 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 65 | $0.00 |
| 86317 | 0% | 137 | $0.00 | |
| 88304 | 0% | 99 | $0.00 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 73 | $0.00 |
| 3044F | 0% | 800 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 754 | $0.00 |
| L1810 | Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 0% | 13 | $0.00 |
| 90739 | 0% | 80 | $0.00 | |
| 57454 | 0% | 26 | $0.00 | |
| 84270 | 0% | 13 | $0.00 | |
| 80324 | 0% | 14 | $0.00 | |
| 83520 | 0% | 82 | $0.00 | |
| 11730 | 0% | 12 | $0.00 | |
| 86704 | 0% | 60 | $0.00 | |
| 86885 | 0% | 39 | $0.00 | |
| 87070 | 0% | 190 | $0.00 | |
| 82784 | 0% | 110 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 108 | $0.00 |
| 82550 | 0% | 50 | $0.00 | |
| 71101 | 0% | 60 | $0.00 | |
| 82746 | 0% | 139 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 78 | $0.00 |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 0% | 41 | $0.00 |
| 84480 | 0% | 76 | $0.00 | |
| 86803 | 0% | 434 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 48 | $0.00 |
| 86592 | 0% | 17 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 173 | $0.00 |
| 90732 | 0% | 98 | $0.00 | |
| 82962 | 0% | 83 | $0.00 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 0% | 63 | $0.00 |
| 82043 | 0% | 662 | $0.00 | |
| 99205 | Prolong outpt/office vis | 0% | 46 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 28 | $0.00 |
| 83021 | 0% | 76 | $0.00 | |
| 87505 | 0% | 36 | $0.00 | |
| 99386 | 0% | 12 | $0.00 | |
| 80359 | 0% | 14 | $0.00 | |
| 73560 | 0% | 24 | $0.00 | |
| 72081 | 0% | 51 | $0.00 | |
| 29075 | 0% | 19 | $0.00 | |
| 88307 | 0% | 17 | $0.00 | |
| 73660 | 0% | 72 | $0.00 | |
| 64615 | 0% | 14 | $0.00 | |
| 73564 | 0% | 182 | $0.00 | |
| 85730 | 0% | 13 | $0.00 | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 0% | 53 | $0.00 |
| 86695 | 0% | 18 | $0.00 | |
| 83002 | 0% | 40 | $0.00 | |
| 96127 | 0% | 57 | $0.00 | |
| 70486 | 0% | 37 | $0.00 | |
| 74022 | 0% | 18 | $0.00 | |
| 86376 | 0% | 35 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 94 | $0.00 |
| 76870 | 0% | 48 | $0.00 | |
| 83880 | 0% | 12 | $0.00 | |
| 70491 | 0% | 15 | $0.00 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 0% | 63 | $0.00 |
| 31231 | 0% | 31 | $0.00 | |
| 94761 | 0% | 20 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 164 | $0.00 |
| 58300 | 0% | 40 | $0.00 | |
| 97010 | 0% | 60 | $0.00 | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 0% | 29 | $0.00 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 42 | $0.00 |
| 87517 | 0% | 15 | $0.00 | |
| 83690 | 0% | 119 | $0.00 | |
| 87536 | 0% | 19 | $0.00 | |
| 11900 | 0% | 19 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 198 | $0.00 |
| 99024 | 0% | 39 | $0.00 | |
| 85379 | 0% | 21 | $0.00 | |
| 90744 | 0% | 19 | $0.00 | |
| 86901 | 0% | 42 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 370 | $0.00 |
| 80197 | 0% | 34 | $0.00 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 0% | 45 | $0.00 |
| 17000 | 0% | 14 | $0.00 | |
| 86160 | 0% | 17 | $0.00 | |
| 96415 | 0% | 35 | $0.00 | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 0% | 16 | $0.00 |
| 87040 | 0% | 22 | $0.00 | |
| 83605 | 0% | 29 | $0.00 | |
| 85610 | 0% | 199 | $0.00 | |
| 84146 | 0% | 48 | $0.00 | |
| 84520 | 0% | 840 | $0.00 | |
| 90661 | 0% | 2,917 | $0.00 | |
| 84100 | 0% | 125 | $0.00 | |
| 90672 | 0% | 94 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 135 | $0.00 |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 0% | 51 | $0.00 |
| 87186 | 0% | 418 | $0.00 | |
| 87185 | 0% | 15 | $0.00 | |
| 90710 | 0% | 141 | $0.00 | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 0% | 30 | $0.00 |
| 84550 | 0% | 125 | $0.00 | |
| 90681 | 0% | 256 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 281 | $0.00 |
| 83540 | 0% | 491 | $0.00 | |
| 86480 | 0% | 39 | $0.00 | |
| 90700 | 0% | 240 | $0.00 | |
| 12011 | 0% | 12 | $0.00 | |
| 86696 | 0% | 18 | $0.00 | |
| 86038 | 0% | 50 | $0.00 | |
| 80061 | Lipid panel | 0% | 2,511 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 1,342 | $0.00 |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 15 | $0.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 52 | $0.00 |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 0% | 195 | $0.00 |
| 82310 | 0% | 402 | $0.00 | |
| 82274 | 0% | 560 | $0.00 | |
| 90734 | 0% | 414 | $0.00 | |
| 86787 | 0% | 131 | $0.00 | |
| 88312 | 0% | 41 | $0.00 | |
| 90713 | 0% | 43 | $0.00 | |
| 98968 | 0% | 19 | $0.00 | |
| 83718 | 0% | 62 | $0.00 | |
| 86336 | 0% | 79 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 72 | $0.00 |
| 85014 | 0% | 228 | $0.00 | |
| J1071 | Injection, testosterone cypionate, 1 mg | 0% | 95 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 69 | $0.00 |
| 90756 | 0% | 93 | $0.00 | |
| 73070 | 0% | 55 | $0.00 | |
| 83655 | 0% | 479 | $0.00 | |
| 83721 | 0% | 146 | $0.00 | |
| 11750 | 0% | 33 | $0.00 | |
| 71250 | 0% | 33 | $0.00 | |
| 86900 | 0% | 42 | $0.00 | |
| 72141 | 0% | 18 | $0.00 | |
| 92133 | 0% | 23 | $0.00 | |
| 84439 | 0% | 634 | $0.00 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 0% | 54 | $0.00 |
| 93015 | 0% | 12 | $0.00 | |
| 86735 | 0% | 33 | $0.00 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 0% | 45 | $0.00 |
| 11100 | 0% | 52 | $0.00 | |
| 86003 | 0% | 325 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 486 | $0.00 |
| 84403 | 0% | 146 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 107 | $0.00 |
| 73080 | 0% | 103 | $0.00 | |
| 84702 | 0% | 214 | $0.00 | |
| 83970 | 0% | 100 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 217 | $0.00 |
| 92579 | 0% | 23 | $0.00 | |
| 82465 | 0% | 94 | $0.00 | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 0% | 46 | $0.00 |
| 73140 | 0% | 257 | $0.00 | |
| 92550 | 0% | 35 | $0.00 | |
| 90691 | 0% | 13 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 146 | $0.00 |
| 82248 | 0% | 56 | $0.00 | |
| 85046 | 0% | 12 | $0.00 | |
| 72070 | 0% | 58 | $0.00 | |
| L3260 | Surgical boot/shoe, each | 0% | 12 | $0.00 |
| 31575 | 0% | 13 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 56 | $0.00 |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 17 | $0.00 |
| 90746 | 0% | 14 | $0.00 | |
| 20552 | 0% | 33 | $0.00 | |
| 99219 | 0% | 63 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 146 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 66 | $0.00 |
| 99225 | 0% | 34 | $0.00 | |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | 0% | 15 | $0.00 |
| 76642 | 0% | 66 | $0.00 | |
| 86765 | 0% | 34 | $0.00 | |
| 17110 | 0% | 133 | $0.00 | |
| 84163 | 0% | 43 | $0.00 | |
| 86677 | 0% | 43 | $0.00 | |
| 90707 | 0% | 243 | $0.00 | |
| 84165 | 0% | 21 | $0.00 | |
| 43235 | 0% | 43 | $0.00 | |
| 73100 | 0% | 73 | $0.00 | |
| 86708 | 0% | 16 | $0.00 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 0% | 21 | $0.00 |
| 90658 | 0% | 17 | $0.00 | |
| 76857 | 0% | 22 | $0.00 | |
| 86431 | 0% | 65 | $0.00 | |
| 86709 | 0% | 13 | $0.00 | |
| 96101 | 0% | 17 | $0.00 | |
| 73000 | 0% | 22 | $0.00 | |
| 76881 | 0% | 20 | $0.00 | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 0% | 27 | $0.00 |
| 00840 | 0% | 23 | $0.00 | |
| 26720 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.